Clinical characteristics and risk factors for antituberculosis drug‐induced hypersensitivity
British Journal of Clinical Pharmacology · 2025
DOI: 10.1111/bcp.16228 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2025. Verfasst von Quanxian Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, People's Republic of China. Hauptthemen laut MEDLINE: Antitubercular Agents, Drug Hypersensitivity. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Science and Technology Fund Project of Guizhou Provincial Health Commission, Sichuan Science and Technology Program Key R&D Project, Open Fund of Key Laboratory of Infectious Diseases and Biosecurity in Guizhou Universities.
Abstract (Originalsprache)
Aims
The aim of this study was to explore the clinical characteristics and risk factors for hypersensitivity reactions induced by antituberculosis drugs.
Methods
A retrospective analysis was conducted on the medical records of patients with active tuberculosis (TB) treated in the TB ward at West China Hospital, Sichuan University, from November 2010 to April 2020.
Results
Out of 7106 patients with active tuberculosis, 205 experienced hypersensitivity reactions to antituberculosis drugs; the incidence of hypersensitivity was 2.9%. The predominant clinical manifestation was a rash, observed in 57.1% (117/205) of these cases. Additionally, 19.0% (39/205) of patients presented with concurrent liver injury. The laboratory parameters white blood cell count, total lymphocyte count, monocyte count, eosinophil count, basophil count, alanine aminotransferase, aspartate aminotransferase and alkaline phosphatase were significantly elevated in patients with hypersensitivity compared to those without. In 38 patients who tested positive for oral antituberculosis drug provocation, 14 (36.8%) were allergic to more than two antituberculosis drugs. Significant risk factors included being female (odds ratio [OR] = 1.387, 95% confidence intervals [CI]: 1.016–1.894), under 65 years of age (OR = 1.826, 95% CI: 1.145–2.913), existing liver disease (OR = 2.464, 95% CI: 1.822–3.333) and a history of allergic diseases (OR = 6.633, 95% CI: 2.681–16.406) and were significantly correlated with hypersensitivity to antituberculosis drugs.
Conclusions
Hypersensitivity reactions to antituberculosis drugs primarily affect the skin, with significant associations observed with liver injury. Females, individuals younger than 65 years, those with pre‐existing liver disease and patients with a history of allergic diseases are at elevated risk for hypersensitivity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, People's Republic of China.
- State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital of Sichuan University, Chengdu, People's Republic of China.
- Department of Tuberculosis, Affiliated Hospital of Zunyi Medical University, Zunyi, People's Republic of China.
- Rehabilitation Department of Traditional Chinese Medicine, People's Hospital of Honghuagang District, Zunyi, People's Republic of China.
ORCID-Profile: Quanxian Liu
Förderung
- Science and Technology Fund Project of Guizhou Provincial Health Commission
- Sichuan Science and Technology Program Key R&D Project
- Open Fund of Key Laboratory of Infectious Diseases and Biosecurity in Guizhou Universities
Zitieren
APA
Liu, Q., Guo, D., Yu, M., Tang, D., Zhang, Y., Luo, M., & He, J. (2025). Clinical characteristics and risk factors for antituberculosis drug‐induced hypersensitivity. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.16228
Vancouver
Liu Q, Guo D, Yu M, Tang D, Zhang Y, Luo M, et al. Clinical characteristics and risk factors for antituberculosis drug‐induced hypersensitivity. British Journal of Clinical Pharmacology. 2025. doi:10.1111/bcp.16228
BibTeX
@article{Liu2025,
author = {Liu, Quanxian and Guo, Dingtao and Yu, Mei and Tang, Daoyan and Zhang, Yongxian and Luo, Mei and He, Jianqing},
title = {Clinical characteristics and risk factors for antituberculosis drug‐induced hypersensitivity},
journal = {British Journal of Clinical Pharmacology},
year = {2025},
doi = {10.1111/bcp.16228}
}
EUVIMED